FDA Inspection 1197605 — Qiagen GmbH
The FDA completed an inspection of Qiagen GmbH on Nov 4, 2022 in Hilden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 4, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Project Evaluation: Devices
- Location
- Hilden (Germany)
Additional details
Postmarket Audit Inspections